Results 31 to 40 of about 551 (144)

An analysis of the impact on total cost of care within a pharmacist‐led comprehensive medication management program

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 7, Issue 10, Page 984-995, October 2024.
Abstract Introduction The rise in health care expenditures continues to pose a significant concern regarding the longevity of the current health care system design. The literature has demonstrated a positive return on investment (ROI) when pharmacists perform medication management services. Building upon positive ROI literature, a clinically integrated
Julie Anne Earby, Tiffany Nicole Jenkins, Abigail Marie Johnson, Victoria Dianne Marchwinski, Devin Marie Schmidt   +4 more
wiley   +1 more source

Antihyperglycaemic Effect of Tetracarpidium Conophorum Nuts in Alloxan Induced Diabetic Female Albino Rats

International Scholarly Research Notices, Volume 2014, Issue 1, 2014., 2014
The antihyperglycaemic activity of Tetracarpidium conophorum nut (walnut) was investigated in albino rats. A total of 20 albino rats were used for the study. The rats were divided into five groups (A–E) of four rats each. Diabetes were induced in the rats except four which served as the positive control group A. Groups B (negative control), C, D, and E
Donatus Onukwufor Onwuli, Holy Brown, Harrison Anaezichukwuolu Ozoani, Z. Canturk, B. Kim, Y. B. Lombardo   +5 more
wiley   +1 more source

Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes

European Journal of Clinical Investigation, Volume 54, Issue 3, March 2024.
Abstract Aims Improving the composition of circulating fatty acids (FA) leads to a reduction in cardiovascular diseases (CVD) in high‐risk individuals. The membrane fluidity of red blood cells (RBC), which reflects circulating FA status, may be a valid biomarker of cardiovascular (CV) risk in type 2 diabetes (T2D).
Giada Bianchetti, Chiara Maria Assunta Cefalo, Carla Ferreri, Anna Sansone, Marilena Vitale, Cassandra Serantoni, Alessio Abeltino, Teresa Mezza, Pietro Manuel Ferraro, Marco De Spirito, Gabriele Riccardi, Andrea Giaccari, Giuseppe Maulucci   +12 more
wiley   +1 more source

Hemichorea associated with non⁃ketotic hyperglycemia: a case report

Chinese Journal of Contemporary Neurology and Neurosurgery, 2012
DOI：10.3969/j.issn.1672⁃6731.2012.03 ...
Chang⁃jie ZHU, Yi⁃ze SHAO, Yan⁃qiu ZHANG   +2 more
doaj  

Effect of metabolic acidosis on glucose reabsorption in rats with acute hyperglycemia

, 1990
The rate of reabsorption of glucose in the kidney is a factor to consider with respect to the degree of hyperglycemia in poorly controlled diabetics. The rate of reabsorption of glucose in the proximal tubule is driven by the electrochemical gradient ...
P. O. Magner, M. L. Halperin
core   +1 more source

Heparin-Induced Thrombocytopenia; Hepatotoxicity with Newer Diabetes Agent; Acute Myocardial Infarction Associated with Albuterol; Olanzapine-Induced Hyperglycemic Hyperosmolar Nonketotic Coma; Paronychia and Skin Hyperpigmentation Due to Gefitinib; Selective Serotonin Reuptake Inhibitor-Induced Enuresis; Do Antidepressants Confer a Decreased Risk for Myocardial Infarction?; Recent Adverse Event Reviews; An Online Interview Discussing the Reduction of ADRs

, 2005
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088).
Joel Shuster
core   +1 more source

[Hyperglycemic hyperosmolar nonketotic coma].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 1990
Ten patients with the syndrome of non-ketotic hyperosmolar coma are described. The mean age of the patients was 62.3 +/- 17.12 years. One patient was 16 years old. In 9 cases the patients had type II diabetes, one had type I diabetes. In 7 cases the coma was the first sign of diabetes. The factor predisposing in most cases was infection.
J, Jaromczyk-Slisz, E, Semetkowska-Jurkiewicz, S, Horoszek-Maziarz   +2 more
openaire   +1 more source

Low-dose Dopamine Treatment of Patients in Nonketotic Hyperosmolar Hyperglycemic Coma

Neurologia medico-chirurgica, 1989
In the acute neurosurgical setting, nonketotic hyperosmolar hyperglycemic coma (NHC) is thought to be caused by cerebral dehydration therapy and administration of steroids, glycerol, or mannitol. The mortality of this complication is reportedly very high, and is due to acute renal and/or cardiac failure.
SHIMODA, Masami, YAMADA, Shinya, SHINODA, Masaki, ODA, Shinri, HIDAKA, Mitsuru, YAMAMOTO, Isao, SATO, Osamu, TSUGANE, Ryuichi   +7 more
openaire   +3 more sources

Coma hiperosmolar

Revista Cubana de Medicina, 2001
Se presentó una revisión concisa y actualizada de la emergencia diabética de mayor mortalidad, el coma hiperosmolar no cetósico, se resaltaron los elementos a tener en cuenta en su definición y los aspectos clínicos fundamentales.
Carmen Remuñán Boue, Jorge Luis Álvarez Rodríguez   +1 more
doaj  

Hyperosmolar hyperglycemic nonketotic coma in Waldenström's macroglobulinemia associated with type II diabetes and complicated by pulmonary tuberculosis.

, 1992
In this paper we describe a successfully treated case of hyperosmolar hyperglycemic non ketotic coma (HHNC). The HHNC was observed in a patient affected by Waldenström's macroglobulinemia, associated with type II diabetes and complicated by pulmonary ...
G. Thiella, S. Ragaini, INVERNIZZI, ROSANGELA, A. Silvani, L. Cirasino   +4 more
core